Four times in her 13 years, Aly Rush has been raced to the hospital with a life-threatening reaction to peanuts. Now she is participating in a groundbreaking experiment: getting once-a month shots of an antibody dubbed Hu-901. It's hoped this drug can block the body's immunoglobulin E (IgE), which sensitizes immune cells to release chemicals such as histamines when exposed to peanuts.
Dr. Donald Leung, pediatric allergy chief at the National Jewish Medical and Research Centre in Denver, says that a few patients tested so far have had significant improvement in symptoms. Leung is very optimistic. In addition to the Denver site, studies are being conducted at six other U.S. centres.
For more information, visit www.peanutallergyresource.com
Dr. Donald Leung, pediatric allergy chief at the National Jewish Medical and Research Centre in Denver, says that a few patients tested so far have had significant improvement in symptoms. Leung is very optimistic. In addition to the Denver site, studies are being conducted at six other U.S. centres.
For more information, visit www.peanutallergyresource.com
0 comments:
Post a Comment